Liqun Yu Selected Research

Liqun Yu Research Topics

Disease

9	Neoplasms (Cancer) 05/2024 - 02/2013
5	Parkinson Disease (Parkinson's Disease) 03/2008 - 12/2003
4	Breast Neoplasms (Breast Cancer) 01/2024 - 10/2016
3	Neoplasm Metastasis (Metastasis) 01/2024 - 01/2019
2	Insulin Resistance 11/2021 - 01/2019
2	Brain Injuries (Brain Injury) 11/2006 - 10/2004
1	Ectopic Pregnancy 02/2024
1	Amyloid Plaque 07/2023
1	Alzheimer Disease (Alzheimer's Disease) 07/2023
1	Papillomavirus Infections 01/2022
1	Acquired Immunodeficiency Syndrome (AIDS) 01/2022
1	Multiple Myeloma 01/2022
1	Obesity 11/2021
1	Acute Erythroblastic Leukemia (Erythroleukemia) 11/2020
1	Metabolic Diseases (Metabolic Disease) 09/2020
1	Hypertension (High Blood Pressure) 09/2020
1	Epilepsy (Aura) 04/2020
1	Carcinoma (Carcinomatosis) 02/2013
1	Huntington Disease (Huntington's Disease) 05/2007
1	Nervous System Diseases (Neurological Disorders) 11/2006
1	Malignant Pleural Effusion 06/2006
1	Pleural Effusion (Pleural Effusions) 06/2006
1	Lung Neoplasms (Lung Cancer) 06/2006
1	Infarction (Infarctions) 10/2004
1	Ischemia 10/2004
1	Dyskinesias (Dyskinesia) 12/2003
1	Psychotic Disorders (Schizoaffective Disorder) 06/2003

Drug/Important Bio-Agent (IBA)

7	Adenosine A2A Receptor (Adenosine A2A Receptors)IBA 03/2008 - 12/2003
3	Proteins (Proteins, Gene)FDA Link 11/2020 - 02/2013
3	Estrogen ReceptorsIBA 10/2020 - 10/2016
3	Adenosine (Adenocard)FDA LinkGeneric 11/2006 - 01/2006
2	Insulin (Novolin)FDA Link 11/2021 - 01/2019
2	Triglycerides (Triacylglycerol)IBA 11/2020 - 01/2019
2	Immunologic Factors (Immunomodulators)IBA 10/2020 - 10/2016
2	ErbB Receptors (EGF Receptor)IBA 10/2016 - 02/2016
2	Neuroprotective AgentsIBA 03/2008 - 12/2003
2	Caffeine (No Doz)FDA LinkGeneric 10/2006 - 01/2006
1	sortase AIBA 05/2024
1	N-Acetylneuraminic Acid (Sialic Acid)IBA 01/2024
1	AntigensIBA 01/2024
1	Sialic Acid Binding Immunoglobulin-like LectinsIBA 01/2024
1	CB2 Cannabinoid ReceptorIBA 07/2023
1	Amyloid (Amyloid Fibrils)IBA 07/2023
1	guanosine 5'-monophosphorothioateIBA 01/2023
1	Cadherins (E-Cadherin)IBA 01/2023
1	16S Ribosomal RNAIBA 01/2022
1	Complement C4 (Complement Component 4)IBA 01/2022
1	CarbohydratesIBA 11/2021
1	AlbuminsIBA 11/2020
1	oxidized low density lipoproteinIBA 11/2020
1	Transaminases (Aminotransferases)IBA 11/2020
1	Aspartic Acid (Aspartate)FDA Link 11/2020
1	Blood Glucose (Blood Sugar)IBA 11/2020
1	CholesterolIBA 11/2020
1	HDL LipoproteinsIBA 11/2020
1	VLDL LipoproteinsIBA 11/2020
1	Phospholipids (Phosphatides)FDA LinkGeneric 11/2020
1	FructosamineIBA 01/2019
1	LigandsIBA 01/2019
1	KetonesIBA 01/2019
1	ProinsulinIBA 01/2019
1	Glucose (Dextrose)FDA LinkGeneric 01/2019
1	Estrogens (Estrogen)FDA Link 01/2019
1	ChromatinIBA 01/2019
1	LeptinIBA 01/2019
1	Fulvestrant (Faslodex)FDA Link 01/2019
1	Tamoxifen FDA LinkGeneric 10/2016
1	Estrogen Receptor Modulators (Antiestrogen)IBA 10/2016
1	Norepinephrine (Noradrenaline)FDA LinkGeneric 02/2013
1	Interleukin-10 (Interleukin 10)IBA 02/2013
1	1- Methyl- 4- phenyl- 1,2,3,6- tetrahydropyridine (MPTP)IBA 03/2008
1	3-nitropropionic acidIBA 05/2007
1	Succinate Dehydrogenase (Fumarate Reductase)IBA 05/2007
1	Dopamine Receptors (Dopamine Receptor)IBA 10/2006
1	Phosphopyruvate Hydratase (Enolase)IBA 06/2006
1	Tumor Biomarkers (Tumor Markers)IBA 06/2006
1	big gastrinIBA 06/2006
1	Keratins (Keratin)IBA 06/2006
1	pro-gastrin-releasing peptide (31-98)IBA 06/2006
1	Peptides (Polypeptides)IBA 06/2006
1	Carcinoembryonic AntigenIBA 06/2006
1	CytokinesIBA 10/2004
1	Dopamine (Intropin)FDA LinkGeneric 12/2003
1	Amphetamine (Amfetamine)FDA LinkGeneric 06/2003

Therapy/Procedure

6	Therapeutics 01/2024 - 12/2003
1	Conservative Treatment 02/2024
1	Salpingostomy 02/2024
1	Salpingectomy 02/2024
1	Immunotherapy 01/2024
1	Oral Administration 11/2021
1	Exercise Therapy (Therapy, Exercise) 04/2020